These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 27684809

  • 1. Polidocanol versus glucose in the treatment of telangiectasia of the lower limbs (PG3T): Protocol for a randomized, controlled clinical trial.
    Bertanha M, Camargo PA, Moura R, Yoshida WB, Pimenta RE, Mariúba JV, Alcantara GP, de Paula DR, Sobreira ML.
    Medicine (Baltimore); 2016 Sep; 95(39):e4812. PubMed ID: 27684809
    [Abstract] [Full Text] [Related]

  • 2. Polidocanol versus hypertonic glucose for sclerotherapy treatment of reticular veins of the lower limbs: study protocol for a randomized controlled trial.
    Bertanha M, Sobreira ML, Pinheiro Lúcio Filho CE, de Oliveira Mariúba JV, Farres Pimenta RE, Jaldin RG, Moroz A, Moura R, Rollo HA, Yoshida WB.
    Trials; 2014 Dec 19; 15():497. PubMed ID: 25527165
    [Abstract] [Full Text] [Related]

  • 3. Polidocanol Plus Glucose Versus Glucose Alone for the Treatment of Telangiectasias: Triple Blind, Randomised Controlled Trial (PG3T).
    Bertanha M, Yoshida WB, Bueno de Camargo PA, Moura R, Reis de Paula D, Padovani CR, Sobreira ML.
    Eur J Vasc Endovasc Surg; 2021 Jan 19; 61(1):128-135. PubMed ID: 32778489
    [Abstract] [Full Text] [Related]

  • 4. Sclerotherapy for Reticular Veins in the Lower Limbs: A Triple-Blind Randomized Clinical Trial.
    Bertanha M, Jaldin RG, Moura R, Pimenta REF, Mariúba JVO, Lúcio Filho CEP, Alcantara GP, Padovani CR, Yoshida WB, Sobreira ML.
    JAMA Dermatol; 2017 Dec 01; 153(12):1249-1255. PubMed ID: 28973414
    [Abstract] [Full Text] [Related]

  • 5. Combination therapy of hyaluronic acid mesotherapic injections and sclerotherapy for treatment of lower leg telangiectasia without major venous insufficiency: a preliminary clinical study.
    Iannitti T, Rottigni V, Torricelli F, Palmieri B.
    Clin Appl Thromb Hemost; 2014 Apr 01; 20(3):326-30. PubMed ID: 23076772
    [Abstract] [Full Text] [Related]

  • 6. Ultrasound-guided sclerotherapy of the great saphenous vein with 1% vs. 3% polidocanol foam: a multicentre double-blind randomised trial with 3-year follow-up.
    Blaise S, Bosson JL, Diamand JM.
    Eur J Vasc Endovasc Surg; 2010 Jun 01; 39(6):779-86. PubMed ID: 20206556
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of great saphenous vein sclerotherapy using standardised polidocanol foam (ESAF): a randomised controlled multicentre clinical trial.
    Rabe E, Otto J, Schliephake D, Pannier F.
    Eur J Vasc Endovasc Surg; 2008 Feb 01; 35(2):238-45. PubMed ID: 17988905
    [Abstract] [Full Text] [Related]

  • 8. A comparative study between cryo-laser cryo-sclerotherapy and sclerotherapy in the treatment of telangiectasia and reticular veins: A randomized controlled trial.
    Nasser MM, Ghoneim BM, Eldaly W, Elmahdy H.
    J Vasc Surg Venous Lymphat Disord; 2024 Jul 01; 12(4):101874. PubMed ID: 38522666
    [Abstract] [Full Text] [Related]

  • 9. Nd:Yag laser combined with injection sclerotherapy in the treatment of reticular veins and telangiectasias (CLaCS method): A triple-blind randomized clinical trial comparing two sclerosing agents associated with same laser patterns.
    Fonseca MM, Mocelin FJ, Grill MH, Gianesini S, Miyake K, Argenta R, Pereira AH.
    Phlebology; 2023 Apr 01; 38(3):165-171. PubMed ID: 36657386
    [Abstract] [Full Text] [Related]

  • 10. The VANISH-2 study: a randomized, blinded, multicenter study to evaluate the efficacy and safety of polidocanol endovenous microfoam 0.5% and 1.0% compared with placebo for the treatment of saphenofemoral junction incompetence.
    Todd KL, Wright DI, VANISH-2 Investigator Group.
    Phlebology; 2014 Oct 01; 29(9):608-18. PubMed ID: 23864535
    [Abstract] [Full Text] [Related]

  • 11. Sclerotherapy of telangiectases and reticular veins: a double-blind, randomized, comparative clinical trial of polidocanol, sodium tetradecyl sulphate and isotonic saline (EASI study).
    Rabe E, Schliephake D, Otto J, Breu FX, Pannier F.
    Phlebology; 2010 Jun 01; 25(3):124-31. PubMed ID: 20483861
    [Abstract] [Full Text] [Related]

  • 12. Sclerotherapy for leg telangiectasia--a blinded comparative trial of polidocanol and hypertonic saline.
    McCoy S, Evans A, Spurrier N.
    Dermatol Surg; 1999 May 01; 25(5):381-5; discussion 385-6. PubMed ID: 10469077
    [Abstract] [Full Text] [Related]

  • 13. 1064 nm Nd:YAG long pulse laser after polidocanol microfoam injection dramatically improves the result of leg vein treatment: a randomized controlled trial on 517 legs with a three-year follow-up.
    Moreno-Moraga J, Smarandache A, Pascu ML, Royo J, Trelles MA.
    Phlebology; 2014 Dec 01; 29(10):658-66. PubMed ID: 23989971
    [Abstract] [Full Text] [Related]

  • 14. Comparison of efficacy and safety between foam sclerotherapy and conventional sclerotherapy: a controlled clinical trial.
    Ukritmanoroat T.
    J Med Assoc Thai; 2011 Mar 01; 94 Suppl 2():S35-40. PubMed ID: 21717876
    [Abstract] [Full Text] [Related]

  • 15. Treating telangiectasias: my method.
    Ferrara F, Ferrara G.
    Minerva Cardioangiol; 2013 Apr 01; 61(2):221-7. PubMed ID: 23492605
    [Abstract] [Full Text] [Related]

  • 16. Chronic venous disease treated by ultrasound guided foam sclerotherapy.
    Smith PC.
    Eur J Vasc Endovasc Surg; 2006 Nov 01; 32(5):577-83. PubMed ID: 16782367
    [Abstract] [Full Text] [Related]

  • 17. Treatment of telangiectasia: comparison of sclerosing agents.
    Carlin MC, Ratz JL.
    J Dermatol Surg Oncol; 1987 Nov 01; 13(11):1181-4. PubMed ID: 3312331
    [Abstract] [Full Text] [Related]

  • 18. Sclerotherapy for lower limb telangiectasias.
    Schwartz L, Maxwell H.
    Cochrane Database Syst Rev; 2011 Dec 07; 2011(12):CD008826. PubMed ID: 22161437
    [Abstract] [Full Text] [Related]

  • 19. Sclerotherapy: a study comparing polidocanol in foam and liquid form.
    Uncu H.
    Phlebology; 2010 Feb 07; 25(1):44-9. PubMed ID: 20118346
    [Abstract] [Full Text] [Related]

  • 20. Polidocanol (aethoxysklerol) for sclerotherapy of superficial venules and telangiectasias.
    Goldman PM.
    J Dermatol Surg Oncol; 1989 Feb 07; 15(2):204-9. PubMed ID: 2644330
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.